Today news
About the same in other media
First alzheimer’s drug Leqembi to slow disease progression gets full FDA approval; check details
Reading now: 485
Medicare and Medicaid Services said Thursday that it will now expand coverage of the drug, broadening access for up to an estimated million people with early forms of the disease. “Today’s action is the first verification that a drug targeting the underlying disease process of Alzheimer’s disease has shown clinical benefit in this devastating disease," Teresa Buracchio, acting director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research, said in the announcement.
Read more on livemint.comAbout this in other media
Mumbai rains: Harbour line trains running late, down line shut at Kurla station. Check details livemint.com /9 months ago
RBL Bank, Delta Corp, 5 others placed under F&O ban on NSE for July 21; check details livemint.com /9 months ago
FIIs continue buying streak pumping ₹3,371 crore in Indian stocks; DII sell ₹193 crore; check details livemint.com /9 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
